Priscilla Liow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Priscilla Liow has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Annamaria Gulla
Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
95 shared publications - Eugenio Morelli
Candiolo Cancer Institute, Torino, Italy
95 shared publications - Jiye Liu
Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston Massachusetts
95 shared publications - Jun Qi
Department of Cancer Biology Dana‐Farber Cancer Institute Boston MA USA
95 shared publications - Keiji Kurata
Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine
95 shared publications - Kenneth Carl Anderson
Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
95 shared publications
Latest Publications
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Ribosome biogenesis and translation signatures are upregulated in BRD9-depletion-sensitive MM cell lines.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Ribosome biogenesis and translation signatures are upregulated in BRD9-depletion-sensitive MM cell lines.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
BRD9 depletion downregulates expression of ribosome biogenesis genes.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
BRD9 depletion downregulates expression of ribosome biogenesis genes.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
BRD9 co-localized with BRD4 and MYC in ribosome biogenesis gene transcription start sites (TSS).
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
BRD9 co-localized with BRD4 and MYC in ribosome biogenesis gene transcription start sites (TSS).
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data S2 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data S2 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Univariate and multivariate analysis of BRD9 expression
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Univariate and multivariate analysis of BRD9 expression
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data S3 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data S3 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Correlations of dBRD9-A susceptibility
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Correlations of dBRD9-A susceptibility
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
BRD9 occupies promoter regions of target gene.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
BRD9 occupies promoter regions of target gene.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Clinical impact and biological significance of BRD9 in multiple myeloma (MM) in vitro and in vivo.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Clinical impact and biological significance of BRD9 in multiple myeloma (MM) in vitro and in vivo.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Materials S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma